diabetes glp-1 vs sglt2 receptor agonists and inhibitors: a couple at last? Insights into the Roles of

Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: a randomized trial

If cramping doesn't improve with hydration and stretching, should I stop semaglutide

Compounded semaglutide is not an FDA-approved finished product

When activated, these receptors can influence neuroinflammation, neuronal excitability, and nociceptive processing, the fundamental components of pain perception

Heres what to consider: Gradual transition : If discontinuing GLP-1 receptor agonists, do so under medical supervision to prevent rapid weight regain

When deciding whether to use GLP-1 (semaglutide or tirzepatide) therapy in adults over 65, the essential question is the same as with any medication: do the benefits outweigh the risks